Content Validation of Quality of Life and Symptom Questionnaires for Pheochromocytoma and Paraganglioma

Stopped early

Conditions studied: Pheochromocytoma, Paraganglioma

In brief

The purpose of this qualitative study is to evaluate the clarity and comprehensiveness of two disease-specific questionnaires, and to evaluate how effective these questionnaires are at assessing the quality of life and symptoms of patients with pheochromocytoma or paraganglioma.

Key facts

Study ID

NCT00911729

Run by

Molecular Insight Pharmaceuticals, Inc.

People needed

24

Starts

2009-04-01

Last updated by the study team

2013-06-10

Who can join

Age: 18 and older. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• Provide written informed consent and be willing to comply with protocol requirements
• Participant is aged ≥ 18
• Have a documented (medical record) diagnosis of either pheochromocytoma or paraganglioma with active symptoms or within 60 days of curative therapy

You may not qualify if…

• Patient is currently asymptomatic from pheochromocytoma/paraganglioma diagnosis or duration > 60 days from curative therapy
• Participant has a clinically significant disorder, including alcohol or drug abuse, which may interfere with study participation or which may affect the outcome of the study as judged by the investigator.
• Participant has a mental disability or significant mental illness, legal incapacity or limited legal capacity or any other lack of fitness, in the investigator's opinion, to preclude the subject's participation in or ability to complete the study.
• Participant is currently too unwell to take part in the study.

Where it is running

• Oxford Outcomes- Nationwide Recruitment within the US — Bethesda, Maryland, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.